Victory Capital Management’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.9K Buy
14,118
+2,283
+19% +$4.05K ﹤0.01% 2369
2025
Q4
$16.8K Buy
+11,835
New +$17.2K ﹤0.01% 2395
2025
Q2
Sell
-13,416
Closed -$10.8K 2488
2025
Q1
$10.8K Sell
13,416
-262
-2% -$302 ﹤0.01% 2450
2024
Q4
$18.9K Sell
13,678
-354
-3% -$397 ﹤0.01% 2449
2024
Q3
$14.6K Sell
14,032
-112
-0.8% -$154 ﹤0.01% 2460
2024
Q2
$24.5K Buy
14,144
+165
+1% +$332 ﹤0.01% 2414
2024
Q1
$33.4K Sell
13,979
-327
-2% -$805 ﹤0.01% 2410
2023
Q4
$47.6K Buy
14,306
+3,206
+29% +$8.59K ﹤0.01% 2439
2023
Q3
$41.5K Sell
11,100
-1,040
-9% -$4.8K ﹤0.01% 2399
2023
Q2
$51.8K Sell
12,140
-187
-2% -$1.1K ﹤0.01% 2382
2023
Q1
$84.3K Sell
12,327
-2,782
-18% -$21.6K ﹤0.01% 2381
2022
Q4
$120K Sell
15,109
-3
-0% -$23 ﹤0.01% 2337
2022
Q3
$145K Buy
15,112
+1,333
+10% +$13.5K ﹤0.01% 2412
2022
Q2
$100K Buy
13,779
+443
+3% +$3.85K ﹤0.01% 2461
2022
Q1
$121K Buy
+13,336
New +$170K ﹤0.01% 2491
2021
Q4
Sell
-97,320
Closed -$1.56M 2784
2021
Q3
$1.56M Sell
97,320
-30,358
-24% -$445K ﹤0.01% 1677
2021
Q2
$1.76M Sell
127,678
-4,837
-4% -$68.5K ﹤0.01% 1668
2021
Q1
$1.94M Buy
132,515
+114,668
+643% +$1.95M ﹤0.01% 1658
2020
Q4
$310K Buy
17,847
+3,737
+26% +$66.5K ﹤0.01% 2274
2020
Q3
$259K Buy
+14,110
New +$262K ﹤0.01% 2214
2020
Q2
Sell
-20,308
Closed -$330K 2653
2020
Q1
$330K Buy
20,308
+8,904
+78% +$165K ﹤0.01% 2218
2019
Q4
$205K Buy
11,404
+1,541
+16% +$28.4K ﹤0.01% 2307
2019
Q3
$200K Buy
+9,863
New +$197K ﹤0.01% 2220

Other funds holding CHRS